Papel de los genes KIR3D en la infección por el virus de hepatitis C
Resumen
Palabras clave
Texto completo:
PDFReferencias
Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol. Hepatol. 2017; 2 (3): 161-76.
WHO. Hepatitis C. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/hepatitis-c.
Cheent K, Khakoo SI. Natural killer cells and hepatitis C: Action and reaction. Gut. 2011; 60 (2): 268-78.
Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microb Infect. 2002; 4 (15): 1545-58
Lanier L. Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol. 2008; 9: 495-502.
Bashirova AA, Martin MP, McVicar DW, Carrington M. The Killer Immunoglobulin-Like Receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet. 2006; 7: 277-300.
Bunce M. Histocompatibility testing. Lidwell and Navarrette C. Imperial College Press, London. 2000; 167-76.
Zhuang YL, Song Y, Zhu C, Zhang Y, Wang D, Nie X, et al. Association of KIR genotypes and haplotypes with syphilis in a Chinese Han population. Scand J Immunol. 2012;75(3): 361-67.
Olsson, M.L. A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Transfusion. 1998; 38(2):168-73.
European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol. Hepatol. 2017; 2 (5): 325-36.
Taborda NA, Hernández JC, Montoya CJ, Rugeles MT. Las células natural killer y su papel en la respuesta inmunitaria durante la infección por el virus de inmunodeficiencia humana tipo-1. Inmunología. 2014; 33(1):11-20.
Chigbu DG, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019; 8(4):376
Fortes MP, Trompiz A, Canonico Y Vargas- Lovelle B, Machado IV, La frecuencia del genotipo I del virus de hepatitis c no ha variado en Venezuela. Rev Colomb Gastroenterol. 2009; 24 (3): 256-58.
Conesa A, Fernández-Mestre M, Padrón D, Toro F, Silva N, Tassinari P et al. Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela. Tissue Antigens. 2010; 75(6):724-9
Dring MM, Morrison MH, McSharry BP, Guinan KJ, Hagan R et al. Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc Natl Acad Sci USA. 2011; 108 (14): 5736-41.
O´Connor GM, McVicar DW. The Yin-Yang of KIR3DL1/S1: Molecular Mechanisms and Celular Function. Crit Rev Immunol. 2013; 33(3):203-18.
DOI: http://dx.doi.org/10.61155/gen.v73i0.524
VIDEOS GEN
Autor: Dr. Freddy Pereira Graterol
CPRE. Sitio de sección del ducto pancreático principal | Drenaje transgástrico de pseudoquiste pancreático | CPRE. Sección del ducto hepático izquierdo por traumatismo de abdomen |
Autora: Dra. Anais Karina García Yaraure
Cavernomatosis portal Pre Colocacion de TIPS. | Cavernomatosis portal Post Colocacion de TIPS. |
Revista GEN
ISSN: 0016-3503 e-ISSN: 2477-975X